Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115761) titled 'Safety and Efficacy of Bupivacaine Liposome Injection for Postoperative Pain Management in Pediatric Congenital Heart Disease Surgeries: A Single-Center, Prospective, Observational Study' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fuwai Central China Cardiovascular Hospital
Condition:
Children with congenital heart disease
Intervention:
Bupivacaine liposome group:After anesthesia, anterior serratus nerve block was performed with 0.25% bupivacaine liposomes at a dose of 0.4ml/kg
Ropivacaine group:After anesthesia, anterior serratus nerve block was performed at...